Abeona Therapeutics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -0.4423 | -100% |
| P/S |
|
30.36 | 33.76 | -10.06% |
|
|
| P/BV |
|
7.17 | 4.82 | 48.67% |
|
|
| P/FCF |
|
0 | 60.98 | -100% |
|
|
| Ev/Ebitda |
|
-2.16 | -22.12 | -90.24% |
|
|
| Ev/S |
|
27.77 | 22.56 | 23.07% |
|
|
| Ev/FCF |
|
-2.6 | 68.75 | -103.79% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1285.77 | 4.83 | -26718.51% | -1697.01 | -24.23% |
| ROE |
|
-365.49 | 9.61 | -3904.78% |
|
|
| ROA |
|
-84.67 | 0.3359 | -25305.34% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-1548.23 | -25.17 | 6051.06% |
|
|
| ROCE |
|
-325.1 | 15.33 | -2220.54% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.12 | -3.67 | -96.73% | -0.1331 | -9.86% |
| Nеt Debt/Ebitda |
|
0.2016 | -3.44 | -105.86% |
|
|
| Debt/Ratio |
|
0.0844 | 0.1972 | -57.2% |
|
|
| Debt/Equity |
|
0 | 1.65 | -100% |
|
|
| Debt/Net Income |
|
-0.0997 | 10.31 | -100.97% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 11.16 | -100% |
| Number of years of dividend growth |
|
1 | 0.1053 | 850% |
|
|
| DSI |
|
1 | 0.2174 | 359.94% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
11.16 | 0.4928 | 2164.9% |
|
|
| Average percentage for payments |
|
65.14 | 43.56 | 49.52% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
3/10
|
16.67 | -56.89 | -129.3% |
| Growth impulse Ebitda 5 years |
|
-33.03 | -64.81 | -49.04% |
| Growth impulse Net Income 5 years |
|
-29.35 | -58.33 | -49.68% |
| Growth impulse FCF 5 years |
|
-46.12 | -47 | -1.87% |
| Growth impulse EPS 5 years |
|
-93.34 | -32.41 | 188% |
IP Score
3.72/10
